Clinicians should be aware of the potential for persistent TIPN and its impact on patients' function and QOL. Future research should focus on large prospective studies with systematic TIPN assessments during and after treatment to better understand which symptoms and patient characteristics predict resolution. This information can guide treatment decisions, balancing the need for effective chemotherapy with minimizing long-term impairments in function and QOL.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- risk factors
- prognostic factors
- case report
- squamous cell carcinoma
- diabetic rats
- patient reported outcomes
- physical activity
- high glucose
- locally advanced
- current status
- radiation therapy
- health information
- risk assessment
- sleep quality
- depressive symptoms
- climate change